Latest Erectile dysfunction Stories
ORLANDO, Fla., Feb. 24, 2011 /PRNewswire/ -- Emerging Media Holdings, Inc. (OTC Bulletin Board: EMDH) announced that its wholly owned subsidiary, Men's Medical Corporation, Inc. has secured a funding commitment to open an Erectile Dysfunction (ED) clinic for the Pittsburgh, Pennsylvania market. Men's Medical has an agreement with eMedical Hub, Inc. to arrange funding for thirty ED clinics across the U.S. over the next three years. The first clinic that Men's Medical secured funding for as...
MINNETONKA, Minn., Feb. 24, 2011 /PRNewswire/ -- American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the full U.S. launch of its new Conceal(TM) Low Profile Reservoir, an enhancement to the already market-leading AMS 700® three-piece inflatable penile prosthesis for the treatment of erectile dysfunction (ED). The Conceal reservoir is compatible with all AMS 700 cylinder and pump...
Erectile dysfunction (ED) is one of the most serious and sensitive of medical problems a man can face. It can destroy self-esteem and ruin relationships. MIami, FL (Vocus/PRWEB) February 22, 2011 Florida Men's Health Center recently opened a second men's health clinic in Aventura/Miami Florida. Erectile dysfunction (ED) is one of the most serious and sensitive of medical problems a man can face. It can destroy self-esteem and ruin relationships. It can reduce an otherwise healthy and...
Accidental damage to thin or buried nerves during surgery can have severe consequences, from chronic pain to permanent paralysis. Scientists at the University of California, San Diego School of Medicine may have found a remedy: injectable fluorescent peptides that cause hard-to-see peripheral nerves to glow, alerting surgeons to their location even before the nerves are encountered.The findings are published in the Feb. 6 advance online edition of the journal Nature Biotechnology.Nerve...
Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction (ED), ejaculatory dysfunction and potential depression. These findings, which...
SADDLE BROOK, N.J., Jan. 6, 2011 /PRNewswire/ -- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the approval of Fortesta comes just months after the FDA's unanimous rejection of Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, many thought it would be the game changer in...
A series of research conducted by age-management leader Cenegenics® Medical Institute with noted UCLA professor Dr. Ernst von Schwarz garnered the medical community's recognition as experts on hormonal therapy Las Vegas, NV (Vocus/PRWEB) January 05, 2011 Cenegenics® Medical Institute, the global age management medicine leader, collaborated with Dr. Ernst R. von Schwarz"”professor of medicine at UCLA's David Geffen School of Medicine"”for a series of scientific review papers...
MOUNTAIN VIEW, Calif., Jan. 5, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Leland Wilson, chief executive officer, will present an overview of the company at the 29th Annual JP Morgan Healthcare Conference. The VIVUS presentation will take place at the Westin St. Francis Hotel in San Francisco, CA on Wednesday, January 12, 2011 at 8:30 a.m. PT. A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com. About VIVUS VIVUS is a...
Age management leader Cenegenics® Medical Institute collaborated with medical experts on various research fronts to determine markers for aging and solutions to slow down chronic disease Las Vegas, NV (Vocus/PRWEB) January 03, 2011 Cenegenics® Medical Institute, the global age management medicine leader, collaborated with experts on various research fronts to determine markers for aging and solutions to slow down chronic disease"”investigating testosterone and growth hormone...
NEW YORK, Dec. 21, 2010 /PRNewswire/ -- As men age, many health issues come to the forefront including depression, erectile dysfunction, premature ejaculation, prostate enlargement (Benign Prostate Hyperplasia), metabolic syndrome, testosterone deficiency, prostate, kidney or bladder cancer, high cholesterol, high blood pressure, loss of muscle mass and vitality. "Sometimes these conditions can cluster, whereby patients will suffer from many of these conditions at once, resulting in...
